Explore more publications!
Sci-Tech News Network
Got News to Share?

Sci-Tech News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 9, 2025

HITC and Evolution Data Centres Announce Strategic Joint Venture to Develop Large-Scale Data Centres in Vietnam
December 9, 2025

HITC and Evolution Data Centres Announce Strategic Joint Venture to Develop Large-Scale Data Centres in Vietnam

Indeterminate EIN Presswire
PubHive Delivers 60% Faster Literature Reporting for MedTech
December 9, 2025

PubHive Delivers 60% Faster Literature Reporting for MedTech

Indeterminate EIN Presswire
Taction Software Expands HIPAA-Compliant Healthcare App Development Across Telemedicine, Physiotherapy, Radiology & SaaS
December 9, 2025

Taction Software Expands HIPAA-Compliant Healthcare App Development Across Telemedicine, Physiotherapy, Radiology & SaaS

Indeterminate EIN Presswire
FEDCON Solicits Security Guard Industry for Input on Government Contracting Strategy
December 9, 2025

FEDCON Solicits Security Guard Industry for Input on Government Contracting Strategy

Indeterminate EIN Presswire
Perdata.ai announces ‘AI Optional’ CONEXUS version
December 9, 2025

Perdata.ai announces ‘AI Optional’ CONEXUS version

Indeterminate EIN Presswire
Veterinary Infusion Pumps Market to Reach $110.8 Million by 2031 at 3.8% CAGR
December 9, 2025

Veterinary Infusion Pumps Market to Reach $110.8 Million by 2031 at 3.8% CAGR

Indeterminate EIN Presswire
2025 Greater Bay Area Science Forum Kicks Off in Guangzhou, Focusing on Industry-Research Synergy
December 9, 2025

2025 Greater Bay Area Science Forum Kicks Off in Guangzhou, Focusing on Industry-Research Synergy

Indeterminate GlobeNewswire
Rio2 Announces Upsize of Previously Announced Bought Deal Financing to C$166 Million
December 9, 2025

Rio2 Announces Upsize of Previously Announced Bought Deal Financing to C$166 Million

Indeterminate GlobeNewswire
Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 9, 2025

Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

Indeterminate GlobeNewswire
Cygnus Metals Limited: Issue of Performance Rights
December 9, 2025

Cygnus Metals Limited: Issue of Performance Rights

Indeterminate GlobeNewswire
Acronis Partners with Synology to Deliver Three-Year Acronis True Image Essentials with BeeDrive and BeeStation
December 9, 2025

Acronis Partners with Synology to Deliver Three-Year Acronis True Image Essentials with BeeDrive and BeeStation

Indeterminate GlobeNewswire
ALT5 Sigma Corp INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALTS)
December 9, 2025

ALT5 Sigma Corp INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALTS)

Indeterminate GlobeNewswire
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
December 9, 2025

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

Indeterminate GlobeNewswire
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
December 9, 2025

ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment

Indeterminate GlobeNewswire
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP
December 9, 2025

ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP

Indeterminate GlobeNewswire
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
December 9, 2025

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions